We report a rare case of miliary tuberculosis (TB) diagnosed in the peripartum period in a 38-year-old woman with a background of Crohn's disease who was on immunosuppressive therapy. This case highlights the diagnostic challenges of TB in pregnancy and postpartum, especially in the context of underlying immunosuppression and non-specific systemic symptoms.
Nelson-PiercyC.Handbook of obstetric medicine sixth edition. CRC Press, Taylor & Francis Group, Boca Raton, FL, 2020. pp. 77–80.
2.
RaveendranA, et al.Tuberculosis in pregnancy. Obstetrician Gynaecol2023; 25: 175–185.
3.
AlıravcıID, et al.Risk of latent tuberculosis infection reactivation in patients treated with tumour necrosis factor antagonists: a five-year retrospective study. Trop Med Infect Dis2025, 10, 90.
4.
JhaDK, et al.Assessment and management for latent tuberculosis before advanced therapies for immune-mediated inflammatory diseases: a comprehensive review. Autoimmun Rev2025; 24: 103758.
5.
LambCA, et al.British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut2019; 68: S1–S106. doi:10.1136/gutjnl-2019-318484.
6.
GordonH, et al.ECCO guidelines on therapeutics in Crohn’s disease: medical treatment. J Crohn’s Colitis2024; 18: 1531–1555.
7.
MoranGW, et al. British Society of Gastroenterology guidelines on inflammatory bowel disease in adults: 2025. Gut2025; 74: s1–s101. doi:10,1136/gutjnl-2024-334295.
8.
HolroydCR, et al.The British Society for Rheumatology Biologic DMARD safety guidelines in inflammatory arthritis—executive summary. Rheumatology2019; 58: 220–226.
